0
0

Cart (0)

Home > Isotope Labelled Standards > Trimetazidine

Trimetazidine - Isotope Labelled Standards
Wishlist
Select options

Trimetazidine-D9 dihydrochloride

  • CAT NUMBER DCTI-A-314
  • CAS NUMBER NA
  • MOLECULAR FORMULA C14H15D9Cl2N2O3 (HCl salt); C14H13D9N2O3 (Free base)
  • MOLECULAR WEIGHT 348.31 (HCl salt); 275.40 (Free base)
Select options
Wishlist
References
FAQ's

References

  1. Souvie, Jean Claude, Process for the preparation of 1-(2,3,4-trimethoxybenzyl) piperazine by reductive amination, ADIR et Cie., France, EP453365B1, November 30, 1994
  1. Courte, S.; Bromet, N, Trace determination of trimetazidine in plasma by high-performance liquid chromatography using fluorescence detection, Journal of Chromatography, Biomedical Applications Volume: 224, Issue: 1, Pages: 162-7, 1981

Frequently Asked Questions

Impurities in Trimetazidine can be a concern because they can affect the medication's quality, safety, and efficacy. Some impurities may be toxic or have undesirable effects on the body, potentially causing adverse reactions or reducing the effectiveness of the treatment.

In analytical techniques, water is used as a solvent to separate and detect Trimetazidine impurities.

Impurities in Trimetazidine are substances that can be present in the medication due to various factors such as the manufacturing process, storage conditions, or degradation. These impurities can include degradation products, residual solvents, or other related compounds that are not the desired active ingredient.

Trimetazidine Impurities should be stored at a controlled room temperature between 2-8°C or as indicated on the Certificate of Analysis (CoA).

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart